Advertisement

1 Growth Stock Down 39% to Buy and Hold for 10 Years

1 Growth Stock Down 39% to Buy and Hold for 10 Years

Having been a publicly traded corporation for two years, Doximity (NYSE: DOCS) -- an online networking platform for medical professionals -- hasn't delivered great returns in this period, far from it. Doximity's shares are down by 39% since 2023 started. Several things are weighing down on the company.